Congenital malformations following phenothiazine administration during pregnancy.
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000818:Animals; D005260:Female; D006330:Heart Defects, Congenital / Q000139:chemically induced*; D006344:Heart Septal Defects, Atrial / Q000139:chemically induced; D006801:Humans; D006849:Hydrocephalus / Q000139:chemically induced; D007231:Infant, Newborn; D009139:Musculoskeletal Abnormalities; D010640:Phenothiazines / Q000009:adverse effects; D011247:Pregnancy; D051381:Rats; D013881:Thioridazine / Q000009:adverse effects*; D014188:Transposition of Great Vessels / Q000139:chemically induced; D014268:Trifluoperazine / Q000009:adverse effects*; D014564:Urogenital Abnormalities
D010640:Phenothiazines; D014268:Trifluoperazine; D013881:Thioridazine